Suchergebnisse - "Claxton, David"

PubPharm (206)

51

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

enthalten in: Annals of hematology | 2021

von Shah, N. | Rakszawski, K. | Nickolich, M. | +13

52

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

enthalten in: Annals of hematology | 2021

von Shah, N. | Rakszawski, K. | Nickolich, M. | +13

53

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

enthalten in: Nature communications | 2021

von Zhu, G. | Luo, H. | Feng, Y. | +18

54

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von List, A. | Sun, Z. | Verma, A. | +14

55

Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia

enthalten in: Cancers | 2021

von Klink, M. | Rahman, M. | Song, C. | +12

56

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

enthalten in: American journal of hematology | 2021

von Zheng, H. | Mineishi, S. | Claxton, D. | +9

57

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

enthalten in: Blood advances | 2021

von Advani, A. | Larsen, E. | Laumann, K. | +20

58

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

enthalten in: American Journal of Hematology | 2021

von Zheng, H. | Mineishi, S. | Claxton, D. | +9

59

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

enthalten in: Cancer | 2021

von Kantarjian, H. | Begna, K. | Altman, J. | +25

60

An Integrated Framework for Genome Analysis Reveals Numerous Previously Unrecognizable Structural Variants in Leukemia Patients’ Samples

enthalten in: bioRxiv.org | 2020

von Xu, J. | Song, F. | Schleicher, E. | +16